RE:Share priceAUSTIN48 wrote: Investment from institutions is dependent on execution and increased weed production.The company is still viewed as a pot producer.
They need to announce Lucky Lake production and increased Duncan production.
Dream water infused with CBD needs FDA approval and new packaging.
Delivra will require the same.
Satipharm should add to the bottom line.
More investment from large institutions is key.
They need to rebrand as a wellness company with cbd products..but most important
they need to make more money..Q4 and Q1 are make or break quarters for HVT ..